The kallikrein–kinin system in diabetic retinopathy: Lessons for the kidney
Diabetic retinopathy and diabetic nephropathy are common microvascular complications of diabetes. The kallikrein–kinin system (KKS) has been implicated in the development of both conditions, and, in particular, bradykinin and its receptors have been shown to exert angiogenic and proinflammatory acti...
Gespeichert in:
| Veröffentlicht in: | Kidney international 2008-05, Vol.73 (10), p.1114-1119 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1119 |
|---|---|
| container_issue | 10 |
| container_start_page | 1114 |
| container_title | Kidney international |
| container_volume | 73 |
| creator | Phipps, J.A. Feener, E.P. |
| description | Diabetic retinopathy and diabetic nephropathy are common microvascular complications of diabetes. The kallikrein–kinin system (KKS) has been implicated in the development of both conditions, and, in particular, bradykinin and its receptors have been shown to exert angiogenic and proinflammatory actions. Several of the key processes that underlie the development of diabetic retinopathy, such as increased vascular permeability, edema, neovascularization, and inflammatory changes, have been associated with the KKS, and recent work has shown that components of the KKS, including plasma kallikrein, factor XIIa, and high-molecular-weight kininogen, are present in the vitreous of people with diabetic retinopathy. The role of the KKS in the development of diabetic nephropathy is controversial, with both adverse and protective effects of bradykinin and its receptors reported. The review examines the role of the KKS in pathways central to the development of diabetic retinopathy and compares this with reported actions of this system in diabetic nephropathy. The possibility of therapeutic intervention targeting bradykinin and its receptors as treatment for diabetic microvascular conditions is considered. |
| doi_str_mv | 10.1038/ki.2008.9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_755133488</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S008525381552855X</els_id><sourcerecordid>69162102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-1dd33e8915016122c5c7342c54b8ab77b852701ea618f50ca9c60d3bd0ccd5493</originalsourceid><addsrcrecordid>eNp9kcFq3DAQhkVJaTabHPoCxQSSkoM3Gsmy5dzK0iaBLb0kZyFLY6LYK28kb2FveYe8YZ-kWnZpIYRcNNLMxz-afwj5DHQGlMvLzs0YpXJWfyATEIznUAlxQCYpJ3ImuDwkRzE-0vSuOf1EDkGyitVCTsjPuwfMOt33rgvo_J_nl85557O4iSMus3SzTjc4OpOFdPphpceHzVW2wBgHH7N2CNm4lXDW4-aYfGx1H_FkH6fk_sf3u_lNvvh1fTv_tshNIWDMwVrOUdYgKJTAmBGm4kUKRSN1U1WNFKyigLoE2QpqdG1KanljqTFWFDWfkq873VUYntYYR7V00WDfa4_DOqo0PnBeSJnI83fJsoaSAWUJPH0FPg7r4NMUKtUBqiJZPSUXO8iEIcaArVoFt9Rho4Cq7SpU59R2FWr7xy97wXWzRPuf3HufgLM9oKPRfRu0Ny7-4xjlrKBUJI7vOEyO_nYYVDQOvUHrAppR2cG90f4vYTShkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>210117410</pqid></control><display><type>article</type><title>The kallikrein–kinin system in diabetic retinopathy: Lessons for the kidney</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Phipps, J.A. ; Feener, E.P.</creator><creatorcontrib>Phipps, J.A. ; Feener, E.P.</creatorcontrib><description>Diabetic retinopathy and diabetic nephropathy are common microvascular complications of diabetes. The kallikrein–kinin system (KKS) has been implicated in the development of both conditions, and, in particular, bradykinin and its receptors have been shown to exert angiogenic and proinflammatory actions. Several of the key processes that underlie the development of diabetic retinopathy, such as increased vascular permeability, edema, neovascularization, and inflammatory changes, have been associated with the KKS, and recent work has shown that components of the KKS, including plasma kallikrein, factor XIIa, and high-molecular-weight kininogen, are present in the vitreous of people with diabetic retinopathy. The role of the KKS in the development of diabetic nephropathy is controversial, with both adverse and protective effects of bradykinin and its receptors reported. The review examines the role of the KKS in pathways central to the development of diabetic retinopathy and compares this with reported actions of this system in diabetic nephropathy. The possibility of therapeutic intervention targeting bradykinin and its receptors as treatment for diabetic microvascular conditions is considered.</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1038/ki.2008.9</identifier><identifier>PMID: 18272958</identifier><identifier>CODEN: KDYIA5</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; bradykinin ; diabetes mellitus ; Diabetes. Impaired glucose tolerance ; Diabetic Nephropathies - etiology ; diabetic nephropathy ; diabetic retinopathy ; Diabetic Retinopathy - etiology ; edema ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Humans ; Kallikrein-Kinin System - physiology ; kallikrein–kinin system ; Kidneys ; Medical sciences ; Nephrology. Urinary tract diseases ; Urinary system involvement in other diseases. Miscellaneous</subject><ispartof>Kidney international, 2008-05, Vol.73 (10), p.1114-1119</ispartof><rights>2008 International Society of Nephrology</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Nature Publishing Group May 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-1dd33e8915016122c5c7342c54b8ab77b852701ea618f50ca9c60d3bd0ccd5493</citedby><cites>FETCH-LOGICAL-c451t-1dd33e8915016122c5c7342c54b8ab77b852701ea618f50ca9c60d3bd0ccd5493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20324005$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18272958$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Phipps, J.A.</creatorcontrib><creatorcontrib>Feener, E.P.</creatorcontrib><title>The kallikrein–kinin system in diabetic retinopathy: Lessons for the kidney</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>Diabetic retinopathy and diabetic nephropathy are common microvascular complications of diabetes. The kallikrein–kinin system (KKS) has been implicated in the development of both conditions, and, in particular, bradykinin and its receptors have been shown to exert angiogenic and proinflammatory actions. Several of the key processes that underlie the development of diabetic retinopathy, such as increased vascular permeability, edema, neovascularization, and inflammatory changes, have been associated with the KKS, and recent work has shown that components of the KKS, including plasma kallikrein, factor XIIa, and high-molecular-weight kininogen, are present in the vitreous of people with diabetic retinopathy. The role of the KKS in the development of diabetic nephropathy is controversial, with both adverse and protective effects of bradykinin and its receptors reported. The review examines the role of the KKS in pathways central to the development of diabetic retinopathy and compares this with reported actions of this system in diabetic nephropathy. The possibility of therapeutic intervention targeting bradykinin and its receptors as treatment for diabetic microvascular conditions is considered.</description><subject>Biological and medical sciences</subject><subject>bradykinin</subject><subject>diabetes mellitus</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diabetic Nephropathies - etiology</subject><subject>diabetic nephropathy</subject><subject>diabetic retinopathy</subject><subject>Diabetic Retinopathy - etiology</subject><subject>edema</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Humans</subject><subject>Kallikrein-Kinin System - physiology</subject><subject>kallikrein–kinin system</subject><subject>Kidneys</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Urinary system involvement in other diseases. Miscellaneous</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kcFq3DAQhkVJaTabHPoCxQSSkoM3Gsmy5dzK0iaBLb0kZyFLY6LYK28kb2FveYe8YZ-kWnZpIYRcNNLMxz-afwj5DHQGlMvLzs0YpXJWfyATEIznUAlxQCYpJ3ImuDwkRzE-0vSuOf1EDkGyitVCTsjPuwfMOt33rgvo_J_nl85557O4iSMus3SzTjc4OpOFdPphpceHzVW2wBgHH7N2CNm4lXDW4-aYfGx1H_FkH6fk_sf3u_lNvvh1fTv_tshNIWDMwVrOUdYgKJTAmBGm4kUKRSN1U1WNFKyigLoE2QpqdG1KanljqTFWFDWfkq873VUYntYYR7V00WDfa4_DOqo0PnBeSJnI83fJsoaSAWUJPH0FPg7r4NMUKtUBqiJZPSUXO8iEIcaArVoFt9Rho4Cq7SpU59R2FWr7xy97wXWzRPuf3HufgLM9oKPRfRu0Ny7-4xjlrKBUJI7vOEyO_nYYVDQOvUHrAppR2cG90f4vYTShkw</recordid><startdate>20080501</startdate><enddate>20080501</enddate><creator>Phipps, J.A.</creator><creator>Feener, E.P.</creator><general>Elsevier Inc</general><general>Nature Publishing</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20080501</creationdate><title>The kallikrein–kinin system in diabetic retinopathy: Lessons for the kidney</title><author>Phipps, J.A. ; Feener, E.P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-1dd33e8915016122c5c7342c54b8ab77b852701ea618f50ca9c60d3bd0ccd5493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>bradykinin</topic><topic>diabetes mellitus</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diabetic Nephropathies - etiology</topic><topic>diabetic nephropathy</topic><topic>diabetic retinopathy</topic><topic>Diabetic Retinopathy - etiology</topic><topic>edema</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Humans</topic><topic>Kallikrein-Kinin System - physiology</topic><topic>kallikrein–kinin system</topic><topic>Kidneys</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Urinary system involvement in other diseases. Miscellaneous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Phipps, J.A.</creatorcontrib><creatorcontrib>Feener, E.P.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Phipps, J.A.</au><au>Feener, E.P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The kallikrein–kinin system in diabetic retinopathy: Lessons for the kidney</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>2008-05-01</date><risdate>2008</risdate><volume>73</volume><issue>10</issue><spage>1114</spage><epage>1119</epage><pages>1114-1119</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><coden>KDYIA5</coden><abstract>Diabetic retinopathy and diabetic nephropathy are common microvascular complications of diabetes. The kallikrein–kinin system (KKS) has been implicated in the development of both conditions, and, in particular, bradykinin and its receptors have been shown to exert angiogenic and proinflammatory actions. Several of the key processes that underlie the development of diabetic retinopathy, such as increased vascular permeability, edema, neovascularization, and inflammatory changes, have been associated with the KKS, and recent work has shown that components of the KKS, including plasma kallikrein, factor XIIa, and high-molecular-weight kininogen, are present in the vitreous of people with diabetic retinopathy. The role of the KKS in the development of diabetic nephropathy is controversial, with both adverse and protective effects of bradykinin and its receptors reported. The review examines the role of the KKS in pathways central to the development of diabetic retinopathy and compares this with reported actions of this system in diabetic nephropathy. The possibility of therapeutic intervention targeting bradykinin and its receptors as treatment for diabetic microvascular conditions is considered.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>18272958</pmid><doi>10.1038/ki.2008.9</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0085-2538 |
| ispartof | Kidney international, 2008-05, Vol.73 (10), p.1114-1119 |
| issn | 0085-2538 1523-1755 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_755133488 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Biological and medical sciences bradykinin diabetes mellitus Diabetes. Impaired glucose tolerance Diabetic Nephropathies - etiology diabetic nephropathy diabetic retinopathy Diabetic Retinopathy - etiology edema Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Humans Kallikrein-Kinin System - physiology kallikrein–kinin system Kidneys Medical sciences Nephrology. Urinary tract diseases Urinary system involvement in other diseases. Miscellaneous |
| title | The kallikrein–kinin system in diabetic retinopathy: Lessons for the kidney |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T13%3A28%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20kallikrein%E2%80%93kinin%20system%20in%20diabetic%20retinopathy:%20Lessons%20for%20the%20kidney&rft.jtitle=Kidney%20international&rft.au=Phipps,%20J.A.&rft.date=2008-05-01&rft.volume=73&rft.issue=10&rft.spage=1114&rft.epage=1119&rft.pages=1114-1119&rft.issn=0085-2538&rft.eissn=1523-1755&rft.coden=KDYIA5&rft_id=info:doi/10.1038/ki.2008.9&rft_dat=%3Cproquest_cross%3E69162102%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=210117410&rft_id=info:pmid/18272958&rft_els_id=S008525381552855X&rfr_iscdi=true |